A detailed history of Marco Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Marco Investment Management LLC holds 140,513 shares of ABBV stock, worth $27.4 Million. This represents 2.23% of its overall portfolio holdings.

Number of Shares
140,513
Previous 127,706 10.03%
Holding current value
$27.4 Million
Previous $23.3 Million 3.63%
% of portfolio
2.23%
Previous 2.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $1.98 Million - $2.31 Million
12,807 Added 10.03%
140,513 $24.1 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $108,677 - $123,828
680 Added 0.54%
127,706 $23.3 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $67,699 - $76,245
492 Added 0.39%
127,026 $19.7 Million
Q3 2023

Nov 07, 2023

SELL
$133.59 - $154.65 $478,652 - $554,110
-3,583 Reduced 2.75%
126,534 $18.9 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $3.71 Million - $4.61 Million
-27,975 Reduced 17.7%
130,117 $17.5 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $44,395 - $51,127
307 Added 0.19%
158,092 $25.2 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $31,811 - $38,150
-230 Reduced 0.15%
157,785 $25.5 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $21,473 - $24,628
160 Added 0.1%
158,015 $21.2 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $21,473 - $24,628
160 Added 0.1%
158,015 $21.2 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $1.42 Million - $1.8 Million
-10,282 Reduced 6.12%
157,855 $24.2 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $27,319 - $33,896
-207 Reduced 0.12%
168,137 $27.3 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $62,416 - $78,975
-581 Reduced 0.34%
168,344 $22.8 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $1.15 Million - $1.3 Million
10,794 Added 6.83%
168,925 $18.2 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $337,198 - $375,658
3,205 Added 2.07%
158,131 $17.8 Million
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $385,875 - $424,802
3,772 Added 2.5%
154,926 $16.8 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $1.79 Million - $2.42 Million
22,259 Added 17.27%
151,154 $16.2 Million
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $1.94 Million - $2.28 Million
22,574 Added 21.23%
128,895 $11.3 Million
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $1.75 Million - $2.35 Million
23,894 Added 28.99%
106,321 $10.4 Million
Q1 2020

Apr 17, 2020

SELL
$64.5 - $97.79 $55,857 - $84,686
-866 Reduced 1.04%
82,427 $6.28 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $14,930 - $18,681
-207 Reduced 0.25%
83,293 $7.38 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $199,142 - $239,426
3,162 Added 3.94%
83,500 $6.32 Million
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $44,347 - $56,686
675 Added 0.85%
80,338 $5.84 Million
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $259,576 - $305,508
-3,365 Reduced 4.05%
79,663 $6.42 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $132,967 - $163,985
-1,708 Reduced 2.02%
83,028 $7.65 Million
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $3,467 - $3,854
39 Added 0.05%
84,736 $8.01 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $38,874 - $45,997
433 Added 0.51%
84,697 $7.85 Million
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $3.99 Million - $5.35 Million
-43,388 Reduced 33.99%
84,264 $7.98 Million
Q4 2017

Feb 15, 2018

SELL
$89.56 - $98.21 $1.73 Million - $1.9 Million
-19,297 Reduced 13.13%
127,652 $12.3 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $94,157 - $120,268
1,348 Added 0.93%
146,949 $13.1 Million
Q2 2017

Aug 11, 2017

BUY
N/A
145,601
145,601 $10.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Marco Investment Management LLC Portfolio

Follow Marco Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marco Investment Management LLC with notifications on news.